BerandaALTME • EPA
add
TME Pharma NV
Tutup sebelumnya
€0,067
Rentang hari
€0,061 - €0,067
Rentang tahun
€0,049 - €0,15
Kapitalisasi pasar
6,15 jt EUR
Volume Rata-Rata
321,25 rb
Rasio P/E
-
Hasil dividen
-
Bursa utama
EPA
Berita pasar
Keuangan
Laporan Laba Rugi
Pendapatan
Penghasilan bersih
| (EUR) | Jun 2025info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 13,50 rb | — |
Biaya operasional | 982,00 rb | -28,24% |
Penghasilan bersih | -1,05 jt | 35,28% |
Margin laba bersih | -7,79 rb | — |
Penghasilan per saham | — | — |
EBITDA | -965,00 rb | 27,74% |
Tarif pajak efektif | — | — |
Neraca
Total aset
Total liabilitas
| (EUR) | Jun 2025info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 2,06 jt | -23,79% |
Total aset | 2,29 jt | -22,06% |
Total liabilitas | 2,86 jt | 108,22% |
Total ekuitas | -570,00 rb | — |
Saham yang beredar | 94,09 jt | — |
Harga terhadap nilai buku | -6,65 | — |
Tingkat pengembalian aset | -105,59% | — |
Tingkat pengembalian modal | -210,54% | — |
Arus Kas
Perubahan kas bersih
| (EUR) | Jun 2025info | Perubahan Y/Y |
|---|---|---|
Penghasilan bersih | -1,05 jt | 35,28% |
Kas dari operasi | -1,43 jt | -4,57% |
Kas dari investasi | 4,00 rb | 200,00% |
Kas dari pembiayaan | 836,00 rb | -47,78% |
Perubahan kas bersih | -590,00 rb | -357,64% |
Arus kas bebas | -555,00 rb | 23,25% |
Tentang
TME Pharma, formerly NOXXON Pharma, is a biotechnology company founded in 1997 in Berlin, Germany which specialises on cancer treatment by targeting the tumor microenvironment. TME Pharma N.V. is listed on Euronext Growth, Paris and is a member of the German Association of Research-Based Pharmaceutical Companies, Verband forschender Arzneimittelhersteller.
TME Pharma develops drugs using technology yielding L-RNA molecules, which are of mirror-image configuration compared to naturally occurring D-RNA molecules. The company calls these agents Spiegelmers, from Spiegel, the German word for "mirror."
The L-RNA are resistant to the natural RNA nuclease enzymes. Wikipedia
Didirikan
1997
Situs
Karyawan
12
